FASTING MIMICKING DIET

/ SCIENCE, SOLUTIONS / By
  1. Fasting–Mimicking Diet and hormone therapy induce breast cancer regression
  2. Fasting–Mimicking Diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity
  3. Fasting–Mimicking Diet promotes Ngn3-driven β-cell regeneration to reverse diabetes
  4. Fasting–Mimicking Diet plus chemotherapy in breast cancer treatment
  5. Fasting–Mimicking Diet modulates microbiota and promotes intestinal regeneration to reduce inflammatory bowel disease pathology
  6. Synergistic effect of Fasting–Mimicking Diet and vitamin C against KRAS mutated cancers
  7. Fasting–Mimicking Diet a clarion call for human nutrition research or an additional swan song for a commercial Diet?
  8. Intermittent administration of a Fasting–Mimicking Diet intervenes in diabetes progression, restores β cells and reconstructs gut microbiota in mice
  9. Fasting Mimicking Diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial
  10. Towards a Fasting–Mimicking Diet for critically ill patients: the pilot randomized crossover ICU-FM-1 study
  11. Neuroprotection of Fasting Mimicking Diet on MPTP-induced Parkinson’s disease mice via gut microbiota and metabolites
  12. Efficacy of a Fasting‐Mimicking Diet in functional therapy for depression: A randomised controlled pilot trial
  13. A Fasting–Mimicking Diet and vitamin C: turning anti-aging strategies against cancer
  14. Exploiting Fasting–Mimicking Diet and metformin to improve the efficacy of platinum-pemetrexed chemotherapy in advanced LKB1-inactivated lung adenocarcinoma …
  15. … trial: study protocol for a randomised, controlled, assessor-blinded intervention trial on the effects of intermittent use of a Fasting–Mimicking Diet in patients with …
  16. Abstract B022: Metabolic and immunologic effects of the Fasting Mimicking Diet in cancer patients
  17. Effects of Fasting–Mimicking Diet and Specific Meal Replacement Foods on Blood Glucose Control in Patients with Type 2 Diabetes: A Randomized …
  18. Author Correction: Fasting–Mimicking Diet and hormone therapy induce breast cancer regression
  19. Protein quantity and source, Fasting–Mimicking Diets, and longevity
  20. Periodic Fasting Mimicking Diet delays cancer development and progression
  21. … (FIT) trial: a randomised, controlled, assessor blinded intervention trial which examines the effect of intermittent use of a Fasting Mimicking Diet in patients with type 2 …
  22. 146P Safety and metabolic effects of Fasting–Mimicking Diet in breast cancer patients
  23. Fasting Mimicking Diets: A literature review of their impact on inflammatory arthritis
  24. Nutrition and Fasting Mimicking Diets in the prevention and treatment of autoimmune diseases and immunosenescence
  25. Fasting Mimicking Diet
  26. Fasting–Mimicking Diet-based non-toxic combination therapy in cancer treatment: from molecules to bedside
  27. Fasting–Mimicking Diet and risk factors for aging, diabetes, cancer, and cardiovascular disease
  28. Safety and metabolic effects of the Fasting Mimicking Diet in cancer patients
  29. Intermittent Administration of a Modified Fasting–Mimicking Diet Reduces Intestinal Inflammation and Promotes Repair to Ameliorate Inflammatory Bowel Disease in …
  30. Five-day Fasting Mimicking Diet (FMD) protocol effects on metabolic markers.
  31. Fasting Mimicking Diet For 5 Days Every Month
  32. Clinical Applications of the Fasting Mimicking Diet
  33. Abstract CT075: Fasting–Mimicking Diet and hormone therapy modulates metabolic factors to promote breast cancer regression and reduce side effects
  34. Fasting Mimicking Diet For 5 Days Every Month
  35. Fasting–Mimicking Diet REDUCES RISK FACTORS FOR AGING-RELATED DISEASES IN PRECLINICAL AND CLINICAL STUDIES
  36. Fasting–Mimicking Diet and hormone therapy modulate metabolic factors to promote breast cancer regression
  37. Metformin+/-cyclic Fasting Mimicking Diet in combination with platinum-pemetrexed chemotherapy for advanced LKB1 inactive lung adenocarcinoma: The FAME trial
  38. A Diet Mimicking Fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms
  39. Fasting Mimicking Diet promotes immunotherapy-associated changes and inhibits autophagy to promote cancer free survival in Acute Lymphoblastic Leukemia …
  40. Fasting Mimicking Diet Is Very Relevant For Health And Longevity
  41. Fasting and engineered Diets as powerful tool in the medical practice: an old approach in the new era
  42. The Effects of Prolonged Fasting/Fasting Mimicking Diet (FMD) on CNS Protection, Regeneration, and Treatment
  43. Fasting‐Mimicking Diet and Risk Factors for Aging, Diabetes, Cancer and Cardiovascular Disease
  44. Fasting and “Fasting Mimicking Diet”(FMD) an effective intervention to promote longevity and health span
  45. Commentary: Fasting–Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity
  46. Safety and feasibility of various Fasting–Mimicking Diets among people with multiple sclerosis
  47. Periodic Fasting Mimicking Diet started late in life reduces and delays carcinogenesis
  48. When Fasting gets tough, the tough immune cells get going—or die
  49. Putting tumours on a Diet
  50. Fasting and β cell regeneration
  51. Can a Diet that mimics Fasting turn back the clock?
  52. Fasting-induced differential stress sensitization in cancer treatment
  53. Calorie restriction for healthy ageing
  54. Intermittent Fasting May Benefit Health
  55. A randomized phase II clinical trial of a Fasting-mimic Diet prior to chemotherapy to evaluate the impact on toxicity and efficacy.
  56. Dietary intervention, a promising adjunct for cancer therapy
  57. The fashion for Fasting
  58. Intermittent Fasting
  59. CORRECTION Open Access
  60. Fast-Mimicking Diets
  61. The Therapeutic Potential of Time-Restricted Fasting on Experimental Ulcerative Colitis
  62. THE EFFECTS OF Fasting ON IMMUNE FUNCTION AND AUTOIMMUNITY
  63. Metabolic Flexibility: Interplay of Diet Composition and Intermittent Fasting on Healthspan (P08-053-19)
  64. Fasting and cancer: molecular mechanisms and clinical application
  65. Fasting improves anticancer immunosurveillance via autophagy induction in malignant cells
  66. Periodic and Intermittent Fasting in Diabetes and Cardiovascular Disease
  67. Fasting, Dietary restriction, and immunosenescence
  68. The longevity Diet: discover the new science behind stem cell activation and regeneration to slow aging, fight disease, and optimize weight
  69. Fasting inhibits hepatic stellate cells activation and potentiates anti‐cancer activity of Sorafenib in hepatocellular cancer cells
  70. The Longevity Diet: Slow Aging, Fight Disease, Optimize Weight
  71. Fasting Physiology and Therapeutic Diets: A Look Back to the Future
  72. Intermittent Fasting and cardiovascular disease: current evidence and unresolved questions
  73. Hematologic Changes After A Mediterranean Diet With Semi-Fasting Intervention For Weight Loss: A Short Term 6-Week Trial
  74. Key Factors for Centenarians
  75. Comparison of glycemic improvement between intermittent calorie restriction and continuous calorie restriction in diabetic mice
  76. Nutrition in the ICU: mechanisms of action and perspectives for optimization
  77. Single Cell Transcriptomics Reconstructs the Embryonic Emergence of HSC and Identifies Ligand-Receptor Interactions Regulating HSC Genesis in the Aorta-Gonad …
  78. To fast, or not to fast before chemotherapy, that is the question
  79. Valter Longo, PhD: Differential Stress-The Effects of Fasting on Cancer
  80. Targeting glucose metabolism to enhance immunotherapy: emerging evidence on intermittent Fasting and calorie restriction mimetics
  81. The effects of meal timing and frequency, caloric restriction, and Fasting on cardiovascular health: an overview
  82. Fasting
  83. Energy and caloric restriction, and Fasting and cancer: a narrative review
  84. Hormones and CBD
  85. A ‘fast’er way to treat breast cancer
  86. Effects of intermittent Fasting Diets on plasma concentrations of inflammatory biomarkers: A systematic review and meta-analysis of randomized controlled trials: Fasting …
  87. Abstract OT3-1-03: DIRECT: A phase II/III randomized trial with Dietary restriction as an adjunct to neoadjuvant chemotherapy for HER2-negative breast cancer
  88. Exercise: an anti-cancer agent
  89. Gut microbiota metabolites in nafld pathogenesis and therapeutic implications
  90. Incorporation of Fasting therapy in an integrative medicine ward: evaluation of outcome, safety, and effects on lifestyle adherence in a large prospective cohort study
  91. Starvation, stress resistance, and cancer
  92. 2085-P: Effects of Intermittent Caloric Restriction on Body Composition and Glucose Tolerance after Fasting and Refeeding
  93. Pancreatic β-cell regeneration: advances in understanding the genes and signaling pathways involved
  94. Effects of short-term Fasting on cancer treatment
  95. Hungry for Health: Fasting‘s medical benefits
  96. kRAS Inhibitor Continues to Impress in NSCLC
  97. Abstract P1-15-20: Dietary REstriction as an adjunct to neoadjuvant ChemoTherapy for HER2-negative breast cancer: Final results from the DIRECT trial (BOOG 2013 …
  98. Specific Dietary interventions to tackle obesity should be a routine part of recommended MS care–Yes
  99. A periodic Diet that mimics Fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan
  100. The influence of Fasting and energy restricting Diets on IGF-1 levels in humans: a systematic review and meta-analysis
  101. Fasting AS THERAPY–A REVIEW
  102. Immune-inflammatory responses in the elderly: an update
  103. The impact of social factors on oncology: The experience of the Reggio Emilia Clinical Cancer Center
  104. Intermittent Fasting as part of the management for T2DM: from animal models to human clinical studies
  105. Diet-Based Interventions Against Cancer
  106. Impact of intermittent Fasting on health and disease processes
  107. When less may be more: calorie restriction and response to cancer therapy
  108. Fasting, circadian rhythms, and time-restricted feeding in healthy lifespan
  109. Tumor treating fields concurrent with standard of care therapy for stage IV NSCLC following platinum failure: Phase III LUNAR study
  110. The Safety and Efficacy of Intermittent Fasting for Weight Loss
  111. Starvation in man.
  112. Fasting Can Prevent Cardiovascular Diseases
  113. The effects of Fasting on drug metabolism
  114. Fasting to enhance Cancer treatment in models: the next steps
  115. Sodium‐glucose co‐transporter inhibitors: Medications that mimic Fasting for cardiovascular prevention
  116. Age as a modifiable risk factor for chronic disease
  117. Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment
  118. Heme oxygenase-1 in tumors: is it a false friend?
  119. Patient nutrition: An overlooked yet emerging variable in the precision oncology equation
  120. Fasting and caloric restriction in cancer prevention and treatment
  121. Thermogenesis-independent metabolic benefits conferred by isocaloric intermittent Fasting in ob/ob mice
  122. Nutrition, inflammation and cancer
  123. Therapeutic use of intermittent Fasting and ketogenic Diet as an alternative treatment for type 2 diabetes in a normal weight woman: a 14-month case study
  124. Personalized Nutrition and Lifestyle Interventions in Systemic Lupus Erythematosus: A Case Report.
  125. Trial watch: Dietary interventions for cancer therapy
  126. Effect of time restricted feeding on the gut microbiome in adults with obesity: A pilot study
  127. Fasting and the late complications of diabetes mellitus: a prospective randomized controlled study in patients with diabetes mellitus type 2
  128. Variability of measured resting metabolic rate
  129. Fasting and its Therapeutic Impact in Brain Tumors
  130. Energy restriction and colorectal cancer: a call for additional research
  131. Persevere or peril: Diabetes care in times of covid-19
  132. Mitochondrion at the crossroad between nutrients and epigenome
  133. The global epidemic of the metabolic syndrome
  134. What can Happen to Your Body Over Months of Isolation
  135. Intermittent Fasting as Part of the Management for T2DM: from Animal Models to Human Clinical Studies
  136. Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection
  137. Differential Stress Resistance (DSR) and Differential Stress Sensitization (DSS); Molecular Mechanisms Behind the Efficacy of Short-Term Starvation (STS)
  138. Low-protein Diet in cancer: ready for prime time?
  139. Effects of a one-week Fasting therapy in patients with type-2 diabetes mellitus and metabolic syndrome–A randomized controlled explorative study
  140. Blood-based therapies to combat aging
  141. Where Does Fat Go With Weight loss?
  142. Effects of alternate-day Fasting, time-restricted Fasting and intermittent energy restriction DSS-induced on colitis and behavioral disorders
  143. Effect of intermittent Fasting on physiology and gut microbiota in presenium rats
  144. A time to fast
  145. ASSESSING THE RELATIONSHIP BETWEEN SERUM IGF-1 AND ADIPOSITY BY AGE IN THE LONG LIFE FAMILY STUDY
  146. Molecular mechanisms of type 2 diabetes mellitus in Chinese
  147. Role of therapeutic Fasting in women’s health: An overview
  148. Autophagy in natural and therapy-driven anticancer immunosurveillance
  149. Dietary influence on central nervous system myelin production, injury, and regeneration
  150. Metabolic Aspects of Aging
  151. Intermittent administration of a leucine-deprived Diet is able to intervene in type 2 diabetes in db/db mice
  152. OPCs on a Diet: A Youthful Serving of Remyelination
  153. Preconditioning strategies to prevent acute kidney injury
  154. Circadian influences of Diet on the microbiome and immunity
  155. IGF-I and the endocrinology of aging
  156. A high-fat Diet: an unexpected role in preventing the metastatic seeding of colorectal cancer
  157. The rationale for a role for Diet and nutrition in the prevention and treatment of cancer
  158. The Benefits of Fasting to Improve Health Conditions and to Prevent Cardiovascular Disease
  159. Clinical management of intermittent Fasting in patients with diabetes mellitus
  160. An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer …
  161. Fasting regulates EGR1 and protects from glucose-and dexamethasone-dependent sensitization to chemotherapy
  162. COULD A GLUTEN-FREE Diet REDUCE YOUR RISK OF DIABETES?
  163. Effect of intermittent vs. daily calorie restriction on changes in weight and patient-reported outcomes in people with multiple sclerosis
  164. Biochemical, Metabolic and Clinical Effects of Intermittent Fasting
  165. The role of trophic factors and inflammatory processes in physical activity-induced neuroprotection in Parkinson’s disease.
  166. Short-Term Fasting induces cell cycle arrest in immature hematopoietic cells and increases the number of naïve T cells in the bone marrow of mice
  167. How Far Are We from Prescribing Fasting as Anticancer Medicine?
  168. Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression
  169. Trial watch: immunogenic cell death induction by anticancer chemotherapeutics
  170. Proceedings of the Seventh International Congress on Vegetarian Nutrition: Introduction
  171. Metabolic impacts of confinement during the COVID-19 pandemic due to modified Diet and physical activity habits
  172. Pushing the limits of cancer therapy: the nutrient game
  173. Genotrophic effect of neurotrophins–Restart of β-cell regeneration in diabetes mellitus
  174. Metabolic alterations at the crossroad of aging and oncogenesis
  175. Modulation of frailty syndrome by Diet: a review of evidence from mouse studies
  176. Potential for Diet to prevent and remediate cognitive deficits in neurological disorders
  177. MET immunohistochemistry should Be avoided in selecting non–small-cell lung cancers requiring MET exon 14 skipping mutation analysis
  178. MicroRNA-223 is essential for maintaining functional β-cell mass during diabetes through inhibiting both FOXO1 and SOX6 pathways
  179. Deconstructing mechanisms of Diet-microbiome-immune interactions
  180. Dietary restriction during the treatment of cancer: Results of a systematic scoping review
  181. Cell Metabolism Clinical and Translational Reports
  182. Short-term, intermittent Fasting induces long-lasting gut health and TOR-independent lifespan extension
  183. Age-related Disease: A Revolution Is Coming
  184. Intermittent Fasting: physiological implications on outcomes in mice and men
  185. Energy-dense versus routine enteral nutrition in the critically ill.
  186. Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy
  187. The impact of diurnal Fasting during ramadan on patients with established cardiac disease: a systematic review
  188. Intermittent Fasting ameliorates PM2. 5 exposure-induced abnormalities in glycaemic control
  189. The role of butyrate in attenuating pathobiont-induced hyperinflammation
  190. Anti-aging Interventions: Caloric Restriction and Beyond
  191. Dietary restrictions and nutrition in the prevention and treatment of cardiovascular disease
  192. Periodic Fasting starves cisplatin‐resistant cancers to death
  193. Screening and referral for psychosocial distress in oncologic practice: use of the Distress Thermometer
  194. Rheumatoid Arthritis Treatment by Regenerative Medicine
  195. A Novel 7-Days Prolonged Dietary Deprivation Regimen Improves ALT and UA After 3–6 Months Refeeding, Indicating Therapeutic Potential
  196. Turning back time with emerging rejuvenation strategies
  197. Antibody Treatment for Rheumatoid Arthritis Was Superior
  198. Intermittent Fasting preserves beta-cell mass in obesity-induced diabetes via the autophagy-lysosome pathway
  199. Feasibility, Process, and Effects of Short-Term Calorie Reduction in Cancer Patients Receiving Chemotherapy: An Integrative Review
  200. Protective effect of Gnetum africanum methanol leaf extract on pancreatic islet cells in rats
  201. GLUTATHIONE, MITOCHONDRIAL DEFECTS, AND A UNIQUE METABOLIC CYCLE IN OLDER HUMANS: IMPLICATIONS FOR SARCOPENIA
  202. Intermittent Fasting promotes adipose thermogenesis and metabolic homeostasis via VEGF-mediated alternative activation of macrophage
  203. Can we rejuvenate? Implications of biological aging research
  204. Islamic Fasting leads to an increased abundance of Akkermansia muciniphila and Bacteroides fragilis group: A preliminary study on intermittent Fasting
  205. Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of Diet and the gut microbiome
  206. Protective effects of short-term Dietary restriction in surgical stress and chemotherapy
  207. Calorie restriction promotes remyelination in a Cuprizone-Induced demyelination mouse model of multiple sclerosis
  208. Telomeres are Important
  209. Low-carb and ketogenic Diets in type 1 and type 2 diabetes
  210. 147P Pharmacokinetics, safety, and efficacy of trastuzumab deruxtecan (T-DXd) with OATP1B/CYP3A inhibitors in patients with HER2-expressing advanced solid …
  211. Type 2 diabetes remission and lifestyle medicine: a position statement from the American College of Lifestyle Medicine
  212. Senotherapeutics: emerging strategy for healthy aging and age-related disease
  213. Effects of intermittent Fasting and energy-restricted Diets on lipid profile: A systematic review and meta-analysis
  214. Structural changes in gut microbiome after Ramadan Fasting: a pilot study
  215. Bursts of reprogramming: a path to extend lifespan?
  216. Gut microbiota during Dietary restrictions: New insights in non-communicable diseases
  217. Regeneration of Pancreatic β-Islet Cells in a Type-II Diabetic
  218. Programmed longevity, youthspan, and juventology
  219. Osteonecrosis of jaw (ONJ) after antiresorptive treatment (bisphosphonates, denosumab) of cancer-treatment induced bone loss (CTIBL): a negligible risk?
  220. From religion to secularism: the benefits of Fasting
  221. Restoring aged stem cell functionality: Current progress and future directions
  222. Global Unsupervised Splicing Analysis of Leukemia Reveals a Persistent Prognostic Signature That Precurses Oncogenesis
  223. The immunologic Warburg effect: Evidence and therapeutic opportunities in autoimmunity
  224. An overview of the current state of evidence for the role of specific Diets in multiple sclerosis
  225. Role of ketogenic Diets in neurodegenerative diseases (Alzheimer’s disease and Parkinson’s disease)
  226. Stratifying nutritional restriction in cancer therapy: Next stop, personalized medicine
  227. Passive induction of experimental allergic encephalomyelitis
  228. Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting
  229. Personalized nutrition: Translating the science of nutrigenomics into practice: Proceedings from the 2018 American college of nutrition meeting
  230. Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes
  231. Unravelling the health effects of Fasting: a long road from obesity treatment to healthy life span increase and improved cognition
  232. How Can We Prolong Our Lives?
  233. Role of timing and dose of energy received in patients with acute lung injury on mortality in the Intensive Nutrition in Acute Lung Injury Trial (INTACT): a post hoc …
  234. Systems approaches needed
  235. Dietary restriction with and without caloric restriction for healthy aging
  236. Mapping the path to a longer life
  237. The microbiota-gut-brain axis in gastrointestinal inflammation and neurological comorbidities
  238. Rationale, feasibility and acceptability of ketogenic Diet for cancer treatment
  239. Exosomes can Regenerate Your Stem Cells
  240. Facing up to the global challenges of ageing
  241. Significance of low-carbohydrate Diets and Fasting in patients with cancer
  242. Nutrition in Oncology: From Treating Cachexia to Targeting the Tumor
  243. Fasting as a therapy in neurological disease
  244. Fasting-refeeding impacts immune cell dynamics and mucosal immune responses
  245. Dietary restriction and epigenetics: part I
  246. HClaimE: A tool for identifying health claims in health news headlines
  247. A pilot study to investigate the immune-modulatory effects of Fasting in steroid-naive mild asthmatics
  248. Intermittent Fasting as a nutrition approach against obesity and metabolic disease
  249. Fasting and Fasting mimetic supplementation address sirtuin expression, miRNA and microbiota composition
  250. Fangchinoline induces apoptosis, autophagy and energetic impairment in bladder cancer
  251. The antidiabetic agent acarbose improves anti-PD-1 and rapamycin efficacy in preclinical renal cancer
  252. Divide and hide: proliferating β-cells control immune tolerance in autoimmune diabetes
  253. Validation of a 3-dimensional photonic scanner for the measurement of body volumes, dimensions, and percentage body fat
  254. Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade
  255. Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)
  256. Effects of Dietary restriction on gut microbiota and CNS autoimmunity
  257. Closed-loop control systems–The quest for precision therapies for diabetes
  258. Chronic Mechanistic Target of Rapamycin Inhibition: Preventing Cancer to Delay Aging or Vice Versa?
  259. Vegetarians have a lower Fasting insulin level and higher insulin sensitivity than matched omnivores: A cross-sectional study
  260. Why We See More Food Allergies
  261. Ketosis in patients undergoing medically supervised therapeutic Fasting—results from an observational trial
  262. A systematic review, meta-analysis, and meta-regression of the impact of diurnal intermittent Fasting during Ramadan on glucometabolic markers in healthy subjects
  263. A biological hypothesis: is it possible that human symbiotic microbiota coding hunger genes for human beings?
  264. Energy restriction enhances adult hippocampal neurogenesis-associated memory after four weeks in an adult human population with central obesity; a randomized …
  265. Metabolic aspects of aging
  266. Ketogenic Diet and Fasting Diet as Nutritional Approaches in Multiple Sclerosis (NAMS): protocol of a randomized controlled study
  267. Autophagy-induced degradation of Notch1, achieved through intermittent Fasting, may promote beta cell neogenesis: implications for reversal of type 2 diabetes
  268. Dietary interventions, cardiovascular aging, and disease: animal models and human studies
  269. Ketogenic Diet With Ketone Supplementation
  270. Current nutritional and pharmacological anti-aging interventions
  271. The molecular link from Diet to cancer cell metabolism
  272. Naturopaths and Herbalists Association of Australia Centenary Conference Abstracts Traditional Practice
  273. Resilience in aging mice
  274. Undigested food and gut microbiota may cooperate in the pathogenesis of neuroinflammatory diseases: a matter of barriers and a proposal on the origin of organ …
  275. Hunger pains: stimulating the appetite of the immune system for Cancer
  276. Resolution of Metabolic syndrome with reduction of visceral adipose tissue in a 47 year old patient with Type 2 Diabetes Mellitus
  277. Diet and supplements in cancer prevention and treatment: Clinical evidences and future perspectives
  278. Long-term effects of very low-carbohydrate Diet with intermittent Fasting on metabolic profile in a social media-based support group
  279. Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors
  280. Scientific and therapeutic effects of self-healing.
  281. The effects of short-term Fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study
  282. The influence of Fasting and energy restricting Diets on blood pressure in humans: a systematic review and meta-analysis
  283. Microbiome-based interventions: therapeutic strategies in cancer immunotherapy
  284. Recent advances in gut microbiota mediated therapeutic targets in inflammatory bowel diseases: emerging modalities for future pharmacological implications
  285. High-intensity therapeutic lifestyle change
  286. Immune by heart: accidental observations inspiring perspective therapeutic/preventive strategies against cancer
  287. Fasting Induces Hepatocellular Carcinoma Cell Apoptosis by Inhibiting SET8 Expression
  288. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study
  289. Therapeutic Time-restricted Feeding Reduces Renal Tumor Bioluminescence in Mice but Fails to Improve Anti-CTLA-4 Efficacy
  290. Ten-hour time-restricted eating reduces weight, blood pressure, and atherogenic lipids in patients with metabolic syndrome
  291. Biological Versus Chronological Aging: JACC Focus Seminar
  292. Epigenetic Regulation by Dietary Restriction: Part II
  293. Practical alternatives to chronic caloric restriction for optimizing vascular function with ageing
  294. LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC) …
  295. Targeting cancer metabolism: Dietary and pharmacologic interventions
  296. Is intermittent Fasting a scientifically-based Dietary method?
  297. Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implications
  298. Inflammageing and metaflammation: the yin and yang of type 2 diabetes
  299. From Regular Catharsis with Castor Oil to Recognizing the Importance of the Intestinal Microbiota
  300. Fasting Drives Nrf2-Related Antioxidant Response in Skeletal Muscle
  301. Diet and longevity: The effects of traditional eating habits on human lifespan extension
  302. Landmark studies and emerging strategies for the management of acute severe ulcerative colitis
  303. Ketogenic therapy in neurodegenerative and psychiatric disorders: from mice to men
  304. Caloric restriction-A promising anti-cancer approach: From molecular mechanisms to clinical trials
  305. Influence of long-term Fasting on blood redox status in humans
  306. Effect of Intermittent Fasting in Patients with Type 2 Diabetes
  307. Intermittent Fasting prompted recovery from dextran sulfate sodium-induced colitis in mice
  308. Intermittent Fasting in cardiovascular disorders—an overview
  309. Diet, gut microbiota and COVID-19
  310. Restructuring of the gut microbiome by intermittent Fasting prevents retinopathy and prolongs survival in db/db mice
  311. The companion dog as a unique translational model for aging
  312. PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration
  313. Immunometabolism of human autoimmune diseases: from metabolites to extracellular vesicles
  314. Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer
  315. Etiology of metabolic syndrome and Dietary intervention
  316. Natural products in the promotion of healthspan and longevity
  317. Intermittent Fasting
  318. Fasting before or after wound injury accelerates wound healing through the activation of pro-angiogenic SMOC1 and SCG2
  319. Integration of immune-metabolic signals to preserve healthy aging
  320. Time-restricted feeding for the prevention of cardiometabolic diseases in high-stress occupations: a mechanistic review
  321. It’s Got Too Greedy. New Therapeutic Options for Metabolic [ally] Addicted NSCLC?
  322. Growth Hormones and Aging 26
  323. Intermittent Fasting benefits on alpha-and beta-cell arrangement in Diet-induced obese mice pancreatic islet
  324. How inflammation blunts innate immunity in aging
  325. Scientific evidence of Diets for weight loss: Different macronutrient composition, intermittent Fasting, and popular Diets
  326. From diabetes care to diabetes cure—the integration of systems biology, eHealth, and behavioral change
  327. The impact of supervised beego, a traditional Chinese water-only Fasting, on thrombosis and hemostasis
  328. Autophagy inducers in cancer
  329. Conditioning Medicine
  330. Human monocyte subsets and phenotypes in major chronic inflammatory diseases
  331. Association of skipping breakfast with cardiovascular and all-cause mortality
  332. Obesity induced T cell dysfunction and implications for cancer immunotherapy
  333. Recent advances in modulating the microbiome
  334. Intermittent Fasting increases the expressions of SODs and catalase in granule and polymorphic cells and enhances neuroblast dendrite complexity and …
  335. Clinical significance of the B7-H4 as a novel prognostic marker in breast cancer
  336. The obese adipose tissue microenvironment in cancer development and progression
  337. Dietary regulation of adult stem cells
  338. Dietary restriction during the treatment of cancer: results of a systematic scoping
  339. Influence of an intervention program promoting voluntary Fasting practices and its perceived barriers among overweight or obese Muslim women working in the …
  340. Preserving Youthful Power
  341. Heme oxygenase inhibition in cancers: possible tools and targets
  342. Interaction between epigenetic and metabolism in aging stem cells
  343. LncRNA MALAT1 induces the dysfunction of β cells via reducing the histone acetylation of the PDX-1 promoter in type 1 diabetes
  344. Diet-induced phenotypic plasticity during aging
  345. Dietary intake regulates the circulating inflammatory monocyte pool
  346. A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice
  347. Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?
  348. The impact of supervised beego, a traditional Chinese water-only Fasting, on thrombosis and hemostasis
  349. Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration
  350. Hormesis in health and chronic diseases
  351. Rejuvenating subventricular zone neurogenesis in the aging brain
  352. Metabolic regulation of macrophage polarization in cancer
  353. The intricate connection between Diet, microbiota, and cancer: a jigsaw puzzle
  354. The business of anti-aging science
  355. Combinatorial Therapy of High Dose Vitamin C and PARP Inhibitors in DNA Repair Deficiency: A Series of 8 Patients
  356. A Literature Review on Intermittent Fasting
  357. Plant-based nutrition for healthcare professionals: implementing Diet as a primary modality in the prevention and treatment of chronic disease
  358. Region-specific proteome changes of the intestinal epithelium during aging and Dietary restriction
  359. Long-Term intensive lifestyle intervention promotes improvement of stage III diabetic nephropathy
  360. Biomedical Research in Aging
  361. Fecal microbiota transplantation in neurological disorders
  362. Acetylation is essential for nuclear heme oxygenase-1-enhanced tumor growth and invasiveness
  363. β-Cell Autophagy in Diabetes Pathogenesis
  364. Sacred and Secular Affliction: Fasting in the history of the West and Western Christianity
  365. Nutrients in the Prevention of Alzheimer’s Disease
  366. The dynamic interplay between the gut microbiota and autoimmune diseases
  367. Lmo4‐resistin signaling contributes to adipose tissue‐liver crosstalk upon weight cycling
  368. Molecular Mechanisms of Intermittent Fasting-induced Ischemic Tolerance
  369. Tetrahydrocurcumin ameliorates diabetes profiles of db/db mice by altering the composition of gut microbiota and up-regulating the expression of GLP-1 in the …
  370. Pair feeding, but not insulin, phloridzin, or rosiglitazone treatment, curtails markers of β-cell dedifferentiation in db/db mice
  371. Finally, a regimen to extend human life expectancy
  372. Pancreatic Islets of Langerhans: Adapting Cell and Molecular Biology to Changes of Metabolism
  373. Effect of time-restricted feeding on metabolic risk and circadian rhythm associated with gut microbiome in healthy males
  374. HO-1 induction in cancer progression: a matter of cell adaptation
  375. Diet as a therapeutic approach to diabetes management and pancreas regeneration
  376. Safety, health improvement and well-being during a 4 to 21-day Fasting period in an observational study including 1422 subjects
  377. The geroscience agenda: Toxic stress, hormetic stress, and the rate of aging
  378. Pain Management And Wound Care Patients: Key Principles
  379. Exploring the microbiome’s potential role in severe COVID-19: possible implications for prevention and treatment
  380. Interrelation of Diet, gut microbiome, and autoantibody production
  381. Modulation of Energy Sensing by Leucine Synergy with Natural Sirtuin Activators: Effects on Health Span
  382. Dietary intake of energy and fiber in MS patients; an approach to prebiotics role
  383. Avoiding holiday seasonal weight gain with nutrient-supported intermittent energy restriction: a pilot study
  384. Intermittent protein restriction improves glucose homeostasis and restores damaged islet beta cells in diabetic mice
  385. Toward a reconceptualization of stem cells from cellular plasticity
  386. Nutritional interventions to improve clinical outcomes in ovarian cancer: a systematic review of randomized controlled trials
  387. An Outlook towards 2019 Novel Coronavirus Pandemic as Per Ayurveda
  388. Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy
  389. Endogenous pancreatic β cell regeneration: A potential strategy for the recovery of β cell deficiency in diabetes
  390. The triumvirate of beta-cell regeneration: solutions and bottlenecks to curing diabetes
  391. Starvation-dependent differential stress resistance: a new frontier for radiotherapy?
  392. The Rationale for a Role for Diet and Nutrition in the Prevention and Treatment of Cancer (Full Text)
  393. Intermittent food restriction in female rats induces SREBP high expression in hypothalamus and immediately postFasting hyperphagia
  394. Assessing successful completion of calorie restriction studies for the prevention and treatment of cancer
  395. Fasting imparts a switch to alternative daily pathways in liver and muscle
  396. 5 MIND’S FRAILTY
  397. Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia
  398. Eat Right for a Long Life
  399. Research progress on the role of intestinal flora in obesity and diabetes intervention
  400. Aging and rejuvenation of neural stem cells and their niches
  401. Mitochondrial fidelity and metabolic agility control immune cell fate and function
  402. The role of Diet in multiple sclerosis: mechanistic connections and current evidence
  403. Dietary Energy Modulation and Autophagy: Exploiting Metabolic Vulnerabilities to Starve Cancer
  404. “Diet and Exercise Will Help You Live Longer”: The Meme that Turns on Housekeeping Genes
  405. Diet, gut microbiota, and vitamins D+ A in multiple sclerosis
  406. Author Archives: Dr Colin Holloway
  407. aging [version 1; peer review: 3 approved]
  408. Vitality Coach, Speaker & Health Consultant
  409. Time-restricted feeding causes irreversible metabolic disorders and gut microbiota shift in pediatric mice
  410. Interaction between microbiota and immunity in health and disease
  411. Alterations in gut microbiota of gestational diabetes patients during the first trimester of pregnancy
  412. β-cell replenishment: Possible curative approaches for diabetes mellitus
  413. The circadian clock, shift work, and tissue-specific insulin resistance
  414. Metformin: Targeting the metabolo-epigenetic link in cancer biology
  415. Dietary modifications for enhanced cancer therapy
  416. Parental death during childhood and depression in young adults–a national cohort study
  417. Optimal non-invasive strategies to reduce recurrent atherosclerotic cardiovascular disease risk
  418. Assessment of the Cardioprotection Offered by Fisetin in H2O2-induced Zebrafish (Danio rerio)-Tg (cmlc2: egfp)
  419. Understanding the tumor immune microenvironment (TIME) for effective therapy
  420. Gut microbiome: profound implications for Diet and disease
  421. The biological clock: a pivotal hub in non-alcoholic fatty liver disease pathogenesis
  422. Mechanisms of aging and potential role of selected polyphenols in extending healthspan
  423. Tumor cell-intrinsic immunometabolism and precision nutrition in cancer immunotherapy
  424. β-cell maturation and identity in health and disease
  425. The effect of time-restricted feeding on glycemic biomarkers: A literature study
  426. Daily intermittent Fasting in mice enhances morphine-induced antinociception while mitigating reward, tolerance, and constipation
  427. The gut–eye axis: lessons learned from murine models
  428. A pooled analysis of two phase II trials evaluating metformin plus platinum-based chemotherapy in advanced non-small cell lung cancer
  429. Ghrelin-mediated hippocampal neurogenesis: implications for health and disease
  430. Overexpression of appoptosin promotes mitochondrial damage in MIN6 cells
  431. Emerging insights into the metabolic alterations in aging using metabolomics
  432. The role of Diet in multiple sclerosis: A review
  433. The geometric framework: An approach for studying the impact of nutrition on healthy aging
  434. Targeted deletion of Insm2 in mice result in reduced insulin secretion and glucose intolerance
  435. Targeted induction of bone marrow mesenchymal stem cells to have effectiveness on diabetic pancreatic restoration
  436. Systems Biology Theory Clarification of a Controversy in Pancreatic Beta Cell Regeneration
  437. Dietary factors in the control of gut homeostasis, intestinal stem cells, and colorectal cancer
  438. Fasting selectively blocks development of acute lymphoblastic leukemia via leptin-receptor upregulation
  439. Fasting and time of day independently modulate circadian rhythm relevant gene expression in adipose and skin tissue
  440. Lycium barbarum L. leaves ameliorate type 2 diabetes in rats by modulating metabolic profiles and gut microbiota composition
  441. Parasite-mediated anorexia and nutrition modulate virulence evolution
  442. Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention
  443. Naturopathic and Herbal Medicine Clinical Practice
  444. Molecular decolonization: an indigenous microcosm perspective of planetary health
  445. Targeting mitochondrial metabolism in neuroinflammation: towards a therapy for progressive multiple sclerosis
  446. Systematic analysis of tRNA-derived small RNAs discloses new therapeutic targets of caloric restriction in myocardial ischemic rats
  447. Prehabilitation and functional recovery for colorectal cancer patients
  448. Ketogenic Diet ameliorates axonal defects and promotes myelination in Pelizaeus–Merzbacher disease
  449. Humanin prevents age-related cognitive decline in mice and is associated with improved cognitive age in humans
  450. On elucidation of the role of mitochondria dysfunction and oxidative stress in multiple sclerosis
  451. Apply Feature Expression Based On Food Energy And Als Algorithm To Recipe Concocting
  452. Cancer metabolism: phenotype, signaling and therapeutic targets
  453. Meta-taxonomic analysis of prokaryotic and eukaryotic gut flora in stool samples from visceral leishmaniasis cases and endemic controls in Bihar State India
  454. Keto Cycling: How to Optimize the Ketogenic Diet and Avoid Common Mistakes
  455. Lactotrehalose, an analog of trehalose, increases energy metabolism without promoting Clostridioides difficile infection in mice
  456. Anticancer effects of the microbiome and its products
  457. Autophagy and intermittent Fasting: the connection for cancer therapy?
  458. What is the evidence for stress resistance and slowed aging?
  459. Low-protein Diet induces IRE1α-dependent anticancer immunosurveillance
  460. Time restricted feeding for the prevention and therapy of lifestyle-dependent diseases: Results of a pilot study in a pre-post design
  461. Effects of timing of food intake and fat/carbohydrate ratio on insulin sensitivity and preconditioning against renal ischemia reperfusion injury by calorie …
  462. Haem oxygenase-1 prevents cell death by regulating cellular iron
  463. Endo-bariatrics: a new paradigm for weight loss
  464. Protein and amino acid restriction, aging and disease: from yeast to humans
  465. Variations in Diet cause alterations in microbiota and metabolites that follow changes in disease severity in a multiple sclerosis model
  466. Dietary influence on estrogens and cytokines in breast cancer
  467. SIRT1 Activation Promotes β‐Cell Regeneration by Activating Endocrine Progenitor Cells via AMPK Signaling‐Mediated Fatty Acid Oxidation
  468. Endolymphatic immunotherapy for advanced hepatocellular carcinoma: an update of our experience
  469. Autophagy in cardiovascular aging
  470. Impact of Ramadan on physical activity and sleeping patterns in individuals with type 2 diabetes: the first study using Fitbit device
  471. Metabolic surgery improves insulin resistance through the reduction of gut-secreted heat shock proteins
  472. Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure
  473. What have we learned on aging from omics studies?
  474. Thyroid function and ischemic heart disease: a Mendelian randomization study
  475. Diet, Gut Microbiome and Multiple Sclerosis
  476. Ketogenic Diet: a new light shining on old but gold biochemistry
  477. Dietary regulation of memory T cells
  478. Effects of acute 3-h swimming exercise on insulin secretion capacity of pancreatic islets
  479. Is the secret for a successful aging to keep track of cancer pathways?
  480. Multi-site neurogenin3 phosphorylation controls pancreatic endocrine differentiation
  481. Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases
  482. Nobiletin fortifies mitochondrial respiration in skeletal muscle to promote healthy aging against metabolic challenge
  483. Reversal of angiotensin ll-induced β-cell dedifferentiation via inhibition of NF-κb signaling
  484. Metabolic impacts of altering meal frequency and timing–does when we eat matter?
  485. Vegetarian Dietary patterns and cardiovascular disease
  486. Effects of a 3-Day High Fat vs High Carbohydrate Diet on Serum Leptin Levels, and Perceived Fatigue in Mild-to-Moderate Multiple Sclerosis
  487. Ficus carica polysaccharide attenuates DSS-induced ulcerative colitis in C57BL/6 mice
  488. Hyperinsulinaemia in cancer
  489. Targeting Her2-Positive Breast Cancer Metabolism Through Dietary and Pharmacological Interventions to Improve Therapeutic Efficacy
  490. Targeting glutathione metabolism: Partner in crime in anticancer therapy
  491. Translating mechanism-based strategies to break the obesity− cancer link: a narrative review
  492. A novel library of-arylketones as potential inhibitors of α-glucosidase: Their design, synthesis, in vitro and in vivo studies
  493. Tissue factor as a mediator of coagulation and signaling in cancer and chronic inflammation
  494. Time-restricted feeding reduces the detrimental effects of a high-fat Diet, possibly by modulating the circadian rhythm of hepatic lipid metabolism and gut …
  495. The effects of the 5: 2 intermittent Fasting Diet and sprint interval training on body composition and markers of cardiovascular and metabolic health in overweight …
  496. Endoplasmic reticulum stress alters ryanodine receptor function in the murine pancreatic β cell
  497. Molecular and computational approach to the link between nutrition and cancer
  498. Precision Medicine in Lifestyle Medicine: The Way of the Future?
  499. The Stem Cell Activation Diet: Your Complete Nutritional Guide to Fight Disease, Support Brain Health, and Slow the Effects of Aging
  500. Dietary restriction and neuroinflammation: a potential mechanistic link
  501. Role of Diet in regulating the gut microbiota and multiple sclerosis
  502. Nutrition, immunity, and cancers
  503. A study on molecular mechanisms of adiposis induced by long-term treatment of high-fat and high-sucrose in C57BL/6J mice.
  504. A Single Bout of 36 Hours of Fasting in Humans Induces Potent Immunomodulatory Effects on Macrophage and Upregulates the Circulation of Multiple Metabolites …
  505. Novel Short-Clustered Maltodextrin as a Dietary Starch Substitute Attenuates Metabolic Dysregulation and Restructures Gut Microbiota in db/db Mice
  506. Practicalities of care closer to home: seven key questions for community psychiatrists
  507. Potential role of the gut microbiota in neuromyelitis optica spectrum disorder: Implication for intervention
  508. Dextran sulfate sodium (DSS)‐induced colitis in mice
  509. Pancreatic Duodenal Homeobox Factor-1 and Neurogenin-3 Serum Expression in Gestational Diabetes
  510. Diagnosis and prognosis of myocardial infarction on a plasmonic chip
  511. Brain structure and function associated with younger adults in growth hormone receptor-deficient humans
  512. Chronic inflammation in the context of everyday life: Dietary changes as mitigating factors
  513. Microbial-based and microbial-targeted therapies for inflammatory bowel diseases
  514. Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages
  515. Dietary modulation of mitochondrial DNA damage: implications in aging and associated diseases
  516. Gut microbiota and their neuroinflammatory implications in Alzheimer’s disease
  517. The autophagic network and cancer
  518. Jinmaitong ameliorates diabetic peripheral neuropathy in streptozotocin-induced diabetic rats by modulating gut microbiota and neuregulin 1
  519. Prolonging Tissue Maintenance to Delay Aging and Cancer
  520. Reversal of phenotypes of cellular senescence by pan-mTOR inhibition
  521. Brain–gut–microbiome interactions in obesity and food addiction
  522. Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients
  523. Sodium butyrate causes α-synuclein degradation by an Atg5-dependent and PI3K/Akt/mTOR-related autophagy pathway
  524. An overview of two decades of Diet restriction studies using Drosophila
  525. Phenotypic landscape of intestinal organoid regeneration
  526. Dietary-and Fasting-based interventions as novel approaches to improve the efficacy of cancer treatment
  527. A study on molecular mechanisms of adiposis induced by long-term treatment of high-fat and high-sucrose in C57BL/6J mice
  528. Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)
  529. Regenerative medicine and cell-based approaches to restore pancreatic function
  530. Genetic background, epigenetic factors and Dietary interventions which influence human longevity
  531. Telomeres, nutrition, and longevity: can we really navigate our aging?
  532. Metabolic control of longevity
  533. Insights on β-cell regeneration from the zebrafish shoal: from generation of cells to functional integration
  534. Challenges, progress, and prospects of developing therapies to treat autoimmune diseases
  535. Chromosomal instability and pro-inflammatory response in aging
  536. Microbiota-governed microRNA-204 impairs endothelial function and blood pressure decline during inactivity in db/db mice
  537. Beneficial effects of sulfated polysaccharides from the red seaweed Gelidium pacificum Okamura on mice with antibiotic-associated diarrhea
  538. It is not all about regeneration: planarians striking power to stand starvation
  539. Metabolic influence on the differentiation of suppressive myeloid cells in cancer
  540. Metabolic reprogramming of fibro/adipogenic progenitors facilitates muscle regeneration
  541. Therapy insight: the effect of tight glycemic control in acute illness
  542. Curcumin induces a fatal energetic impairment in tumor cells in vitro and in vivo by inhibiting ATP-synthase activity
  543. Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma
  544. Fecal metaproteomic analysis reveals unique changes of the gut microbiome functions after consumption of sourdough Carasau bread
  545. Diet in Parkinson’s disease: critical role for the microbiome
  546. Autophagy in multiple sclerosis: Two sides of the same coin
  547. Importance of Dietary changes during the coronavirus pandemic: how to upgrade your immune response
  548. Connecting the metabolic and immune responses to cancer
  549. Lifestyle-based modifiable risk factors in multiple sclerosis: review of experimental and clinical findings
  550. Lysosomes mediate benefits of intermittent Fasting in cardiometabolic disease: the janitor is the undercover boss
  551. Autophagy and ubiquitination as two major players in colorectal cancer: a review on recent patents
  552. Dietary approaches to cancer therapy
  553. Is autophagy involved in the diverse effects of antidepressants?
  554. Circadian rhythm of lipid metabolism in health and disease
  555. Characterization of the intestinal microbiota during Citrobacter rodentium infection in a mouse model of infection-triggered Parkinson’s disease
  556. The Gut–Eye Axis: Lessons Learned from Murine Models
  557. Ghrelin mediated hippocampal neurogenesis–implications for health and
  558. Healthful aging mediated by inhibition of oxidative stress
  559. Jump Start Autophagy: Activate Your Body’s Cellular Healing Process to Reduce Inflammation, Fight Chronic Illness and Live a Longer, Healthier Life
  560. Anti-aging effects of calorie restriction (CR) and CR mimetics based on the senoinflammation concept
  561. Longevity: lesson from model organisms
  562. Fructose promotes cytoprotection in melanoma tumors and resistance to immunotherapy
  563. Oxidized lipoproteins promote resistance to cancer immunotherapy independent of patient obesity
  564. Obesity may accelerate the aging process
  565. Considerations for successful cancer immunotherapy in aged hosts
  566. A realist review of digital behaviour change models for cardiac rehabilitation: current challenges and future prospects
  567. Proposed mechanisms for bariatric surgery-induced improvement and resolution of clinical manifestations of type II diabetes
  568. Sodium butyrate exacerbates Parkinson’s disease by aggravating neuroinflammation and colonic inflammation in MPTP-induced mice model
  569. Curriculum Vitae-Pinchas Cohen
  570. Stanniocalcin-2 contributes to mesenchymal stromal cells attenuating murine contact hypersensitivity mainly via reducing CD8+ Tc1 cells
  571. Differentiation impairs Bach1 dependent HO-1 activation and increases sensitivity to oxidative stress in SH-SY5Y neuroblastoma cells
  572. Inhibition of Nrf2 enhances the anticancer effect of 6-O-angeloylenolin in lung adenocarcinoma
  573. Peroxisome Proliferator-Activated Receptors and Caloric Restriction—Common Pathways Affecting Metabolism, Health, and Longevity
  574. Metformin: current clinical applications in nondiabetic patients with cancer
  575. Impact of Short-term Calorie Restriction on HER2-Overexpressing Breast Cancer
  576. Heme Oxygenase Dependent Bilirubin Generation in Vascular Cells: A Role in Preventing Endothelial Dysfunction in Local Tissue Microenvironment?
  577. Metabolic Constrains Rule Metastasis Progression
  578. Calorie restriction in rodents: caveats to consider
  579. Towards a comprehensive etiopathogenetic and pathophysiological theory of multiple sclerosis
  580. Drosophila as a model for ageing
  581. Impaired function of the suprachiasmatic nucleus rescues the loss of body temperature homeostasis caused by time-restricted feeding
  582. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies
  583. EGF suppresses the expression of miR-124a in pancreatic β cell lines via ETS2 activation through the MEK and PI3K signaling pathways
  584. The Natural Prescription: A Doctor’s Guide to the Science of Natural Medicine
  585. FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury
  586. When wrinkles appear on the immune system can it be reversed?
  587. Breaking bad and breaking good: β-cell autophagy pathways in diabetes
  588. Repurposing tin mesoporphyrin as an immune checkpoint inhibitor shows therapeutic efficacy in preclinical models of cancer
  589. Sufism and Optimal Health
  590. Nutritional regulation of intestinal stem cells
  591. The appendix in Parkinson’s Disease: from vestigial remnant to vital organ?
  592. Onetime party drug hailed as miracle for treating severe depression
  593. Cancer-germline antigen expression discriminates clinical outcome to CTLA-4 blockade
  594. Genome-wide analysis reveals distinct genetic mechanisms of Diet-dependent lifespan and healthspan in D. melanogaster
  595. Prebiotics and the Modulation on the Microbiota-GALT-Brain Axis
  596. Impact of Human Microbiome on Health
  597. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker
  598. Epigenetic effects of gut metabolites: exploring the path of Dietary prevention of type 1 diabetes
  599. and Reema Verma
  600. Dietary Restriction, Physical Activity, and Metabolism: Potential Role of Intermittent Fasting for Reducing Obesity
  601. The core clock transcription factor BMAL1 drives circadian β-cell proliferation during compensatory regeneration of the endocrine pancreas
  602. Paraoxonases activities and polymorphisms in elderly and old-age diseases: An overview
  603. Anti-senescence compounds: a potential nutraceutical approach to healthy aging
  604. Metabolic Reprogramming of Fibro/Adipogenic Progenitors Facilitates Muscle Regeneration
  605. In Vivo Cell Conversion as a New Cell Therapy
  606. Amino acid deprivation triggers a novel GCN2-independent response leading to the transcriptional reactivation of non-native DNA sequences
  607. A framework for uncovering the roles of calories and macronutrients in health and aging
  608. Using single cell analysis for translational studies in immune mediated diseases: opportunities and challenges
  609. Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity
  610. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation
  611. Innovation in Public Health: a behavioral and design sciences approach
  612. Bi-stability in type 2 diabetes mellitus multi-organ signalling network
  613. LKB1 and tumor metabolism: the interplay of immune and angiogenic microenvironment in lung cancer
  614. Dietary protein, metabolism, and aging
  615. Immunogenic stress and death of cancer cells in natural and therapy-induced immunosurveillance
  616. Cell intrinsic and systemic metabolism in tumor immunity and immunotherapy
  617. Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells
  618. Organic compound farnesol reduces disease severity and onset in mouse model of Multiple Sclerosis
  619. Brighten Up Syllabus
  620. Fasting: A Guide to Health and Wellness
  621. Expression of the ZIP/SLC39A transporters in β-cells: a systematic review and integration of multiple datasets
  622. Intestinal transit bipartition, the new era in metabolic surgery for type 2 diabetes
  623. Healthy aging: a bibliometric analysis of the literature
  624. Chronic Inflammation Can Cause Many Diseases
  625. Fast. Feast. Repeat.: The Comprehensive Guide to Delay, Don’t Deny® Intermittent Fasting–Including the 28-Day FAST Start
  626. Differential Effects of Starvation in Normal and Cancer Cells: From EGR1-Dependent Protection to p53-Mediated Apoptosis
  627. Innate immune cells and their contribution to T-cell-based immunotherapy
  628. Latest Therapies for Type 1 Diabetes: Exsisting Setup and “Post-Insulin” Standpoints
  629. Kick Diabetes Essentials: The Diet and Lifestyle Guide
  630. Integrating pharmacology and microbial network analysis with experimental validation to reveal the mechanism of composite Sophora colon-soluble capsule …
  631. Immunogenic Stress and Death
  632. Starving Cancer from the Inside and Outside: Nutrient Stress in Combination with Autophagy Inhibition to Kill Pancreatic Ductal Adenocarcinoma (PDAC)
  633. Nutraceuticals targeting generation and oxidant activity of peroxynitrite may aid prevention and control of Parkinson’s disease
  634. The Impact of Time-Restricted Eating on Circulating Factors, Insulin Sensitivity and Circadian Rhythms
  635. Therapeutic efficacy of a combined sage and bitter apple phytopharmaceutical in chronic DSS-induced colitis
  636. Genome-wide analysis reveals distinct genetic mechanisms of Diet-dependent lifespan 1 and healthspan in D. melanogaster 2
  637. Sodium Butyrate Exacerbates Parkinson’s Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model
  638. In search of rationality in human longevity and immortality
  639. Axonal degeneration during aging and its functional role in neurodegenerative disorders
  640. Mitogen-activated protein kinases, Fus3 and Kss1, regulate chronological lifespan in yeast
  641. When Stress Becomes Abnormal
  642. Twice subacute MPTP administrations induced time-dependent dopaminergic neurodegeneration and inflammation in midbrain and ileum, as well as gut microbiota …
  643. The Effect of Time-Restricted Feeding on Body Weight, Energy, Mood, Sleep, and Hunger Levels of Adults on Social Media
  644. Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity
  645. Targeting the Warburg effect for cancer therapy: A long and winding road
  646. The Role of Autoimmunity in Progression of Renal Injury in a Murine Model of Systemic Lupus Erythematosus
  647. Metabolic Control of Longevity
  648. Pancreatic Cancer (PDAC): introduction of evidence-based complementary measures into integrative clinical management
  649. Understanding the Impact of Diet and Obesity on Anti-tumor Immunity and Therapeutic Efficacy in Kidney Cancer
  650. Resetting the aging clock: implications for managing age-related diseases
  651. The gut microbiome in Parkinson’s disease: A culprit or a bystander?
  652. Glow15: A Science-based Plan to Lose Weight, Revitalize Your Skin, and Invigorate Your Life
  653. This Book Could Save Your Life: The Science of Living Longer Better
  654. A complex auxiliary: IL-17/Th17 signaling during type 1 diabetes progression
  655. Microbiome report
  656. Aging epigenetics: changes and challenges
  657. Where is the clinical breakthrough of heme oxygenase-1/carbon monoxide therapeutics?
  658. Single-Cell RNA-seq Reveals a Subpopulation of Cells Underlying β Cell Expansion in the Postnatal Islets
  659. Total Reference List MSM 2016
  660. Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced mouse models of …
  661. Resisting resistance to immune checkpoint therapy: a systematic review
  662. The Effects of a Modified Ketogenic Diet on Clinical, Behavioral, Genetic, and Demyelinating Inflammatory Immune Responses in the Experimental Autoimmune …
  663. Optimal Men’s Health
  664. Autophagy Dysregulation and Lipid Droplet Accumulation in Pancreatic β-Cells Under Metabolic Stress
  665. Bioinformatic Analysis of Circadian Reprogramming Events
  666. Relationships between ion channels, mitochondrial functions and inflammation in human aging
  667. Perception of Infection: Behavioral and Physiological Responses to Illness-Related Social Cues
  668. ANTI-AGING GENE THERAPY STUDIES ON MODEL ORGANISMS
  669. Low-level ionizing radiation induces selective killing of HIV-1-infected cells with reversal of cytokine induction using mTOR Inhibitors
  670. Epigenetics of Aging and Longevity: Translational Epigenetics vol 4
  671. Dead Execs Don’t Get Bonuses: The Ultimate Guide to Surviving Your Career with a Healthy Heart
  672. Innate Lymphoid Cells and Cholesterol Metabolism in Intestinal Barrier Function
  673. Novel Approaches For The Identification And Targeted Clearance Of Senescent Cells, As A Therapeutic Strategy For Senescence-Related And Age-Related Diseases
  674. Characterizing Mouse Aging Organism-wide with RNA-Sequencing and Single-cell RNA-Sequencing
  675. On Aging, Behavior and the Role of PA28αβ in Protein Homeostasis
  676. Praise for LIFESPAN
  677. Post-hunter-gatherer era microbes’ role in allergic/autoimmune diseases
  678. Health in an Ecological Civilization: Towards a Process Understanding of the Dialectics of Health
  679. Effects of feed restriction on milk production and metabolism in mid-lactation dairy cows
  680. Cardiovascular Risk Factors and Markers
  681. Characterization of Igfr-L1 and Igfr-L2 as two novel regulators of the Ins/Igf system
  682. Role of macrophage-derived heme oxygenase-1 in tumor microenvironment
  683. Pain Is Not What It Seems: The Guide to Understanding and Healing from Chronic Pain and Suffering
  684. Prehabilitation in Colorectal Cancer Surgery
  685. Metabolic Regulation of Anti-Tumor CD8+ T Cell Responses
  686. Immunomodulation by raw bovine milk and its ingredients: effects in nutritional intervention, oral vaccination and trained immunity
  687. Fasting–Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
  688. Fasting–Mimicking Diet prevents high-fat Diet effect on cardiometabolic risk and lifespan
  689. Fasting–Mimicking Diet blocks triple-negative breast cancer and cancer stem cell escape
  690. Quality of life and illness perceptions in patients with breast cancer using a Fasting Mimicking Diet as an adjunct to neoadjuvant chemotherapy in the phase 2 …
  691. Fasting–Mimicking–Diet does not reduce skeletal muscle function in healthy young adults: a randomized control trial
  692. Effect of Fasting–Mimicking Diet or Continuous Energy Restriction on Weight Loss, Body Composition, and Appetite-Regulating Hormones Among Metabolically …
  693. Improvement of Non‐Alcoholic Fatty Liver Disease in Mice by Intermittent Use of a Fasting‐Mimicking Diet
  694. Intermittent caloric restriction with a modified Fasting–Mimicking Diet ameliorates autoimmunity and promotes recovery in a mouse model of multiple sclerosis
  695. Safety and feasibility of Fasting–Mimicking Diet and effects on nutritional status and circulating metabolic and inflammatory factors in cancer patients …
  696. Intermittent administration of a Fasting–Mimicking Diet reduces intestinal inflammation and promotes repair to ameliorate inflammatory bowel disease in mice
  697. Cancer and Fasting: Can Fasting/Calorie Restriction (CR) or Fasting–Mimicking Diet (FMD) Help Fight Cancer? Molecular Basis of Fasting Response
  698. Periodic Fasting prevents fat penalties in females
  699. More evidence of the benefits of Fasting
  700. Glycemic Control by Umbilical Cord-Derived Mesenchymal Stem Cells Promotes Effects of Fasting–Mimicking Diet on Type 2 Diabetes
  701. Fasting and Fasting–Mimicking Diets for chemotherapy augmentation
  702. Time-Restricted Eating, Intermittent Fasting, and Fasting–Mimicking Diets in Weight Loss
  703. An Intermittent Fasting Mimicking Nutrition Bar Extends Physiologic Ketosis in Time Restricted Eating: A Randomized, Controlled, Parallel-Arm Study
  704. Intermittent Fasting: promising premises or broken promises?
  705. A review of Fasting effects on the response of cancer to chemotherapy
  706. The effects of physical activity, fast-Mimicking Diet and psychological interventions on cancer survival: A systematic review and meta-analysis of randomized …
  707. Do Fasting, CR and FMD Improve the Chemotherapy Response, Reduce Off-Target Toxicities and Enhance Antitumour Immunity? Illusion or Clinical Reality?
  708. Intermittent Fasting–Mechanisms and Clinical Usefulness
  709. Therapeutic Fasting reduces adverse effects of cancer treatments.
  710. Comparative effects of calorie restriction on health span and in-sulin resistance: classic calorie restriction Diet vs ketosis-induc-ing Diet
  711. Diet composition influences the metabolic benefits of short cycles of very low caloric intake
  712. Beneficial gut microbiome remodeled during intermittent Fasting in humans
  713. Current Evidence and Directions for Intermittent Fasting During Cancer Chemotherapy
  714. Dietary patterns affect Parkinson’s disease via the microbiota-gut-brain axis
  715. Enhancing endocrine therapy activity via Fasting cycles: biological rationale and clinical feasibility
  716. Effects of Calorie Restriction on Health Span and Insulin Resistance: Classic Calorie Restriction Diet vs. Ketosis-Inducing Diet
  717. Interview with Professor Valter Longo
  718. A six-month periodic Fasting reduces microalbuminuria and improves metabolic control in patients with type 2 diabetes and diabetic nephropathy: a randomized …
  719. A plateful of medicine
  720. Role of ketones, ketogenic Diets and intermittent Fasting in ICU
  721. The anti-tumor efficacy of 20 (S)-protopanaxadiol, an active metabolite of ginseng, according to Fasting on hepatocellular carcinoma
  722. Intermittent Fasting: from calories to time restriction
  723. BREAKING INSIGHTS
  724. Engineered Diets to improve cancer outcomes
  725. A systematic analysis of Diet-induced nephroprotection reveals overlapping and conserved changes in cysteine catabolism
  726. Intermittent Fasting in the prevention and treatment of cancer
  727. Intermittent and periodic Fasting, longevity and disease
  728. NEW PERSPECTIVES ON NUTRITION AND IMMUNE HEALTH IN COMBAT SPORTS
  729. Fasting for Cardiovascular Health
  730. The role and its mechanism of intermittent Fasting in tumors: friend or foe?
  731. Blue Zone Lessons and Longevity Diets
  732. Gut microbiota modulation as a possible mediating mechanism for Fasting-induced alleviation of metabolic complications: a systematic review
  733. Fasting: How to Guide
  734. ROS-responsive organosilica nanocarrier for the targeted delivery of metformin against cancer with the synergistic effect of hypoglycemia
  735. Intermittent Fasting
  736. Antiaging Diets: Separating fact from fiction
  737. A Clinical Perspective of Low Carbohydrate Ketogenic Diets: A Narrative Review
  738. Molecular mechanisms of Dietary restriction promoting health and longevity
  739. The association of skipping breakfast with cancer-related and all-cause mortality in a national cohort of United States adults
  740. Are periods of feeding and Fasting protective during critical illness?
  741. Targeting metabolic adaptations in the breast cancer liver metastatic niche using Dietary approaches to improve endocrine therapy efficacy
  742. Recent advances in the field of caloric restriction mimetics and anti-aging molecules
  743. TP53/p53-FBXO22-TFEB controls basal autophagy to govern hormesis
  744. Intermittent Fasting for obesity and related disorders: unveiling myths, facts, and presumptions
  745. Metabolic Signatures of Cancer Cells–382
  746. Intermittent and periodic Fasting, hormones, and cancer prevention
  747. Observational study of lipid profile and c-reactive protein after a seven-day fast
  748. Low Carbohydrate Diets in Cancer Therapeutics: Current Evidence
  749. The Role of Nutritional Lifestyle and Physical Activity in Multiple Sclerosis Pathogenesis and Management: A Narrative Review
  750. LKB1 cooperates with Sox17 to drive metastasis
  751. Dietary restrictions modulate the gut microbiota: Implications for health and disease
  752. Exercise, Diet and Sleeping as Regenerative Medicine Adjuvants: Obesity and Ageing as Illustrations
  753. Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer
  754. Nutritional control of intestinal stem cells in homeostasis and tumorigenesis
  755. Essential amino acid formulations to prevent mitochondrial dysfunction and oxidative stress
  756. Daily caloric restriction limits tumor growth more effectively than caloric cycling regardless of Dietary composition
  757. Hunger Brings Down the Tumor Fort
  758. A CASE REPORT: POSTPRANDIAL HYPOGLYCAEMIA IN INTERMITTENT Fasting Diet FOR TYPE 2 DIABETES MELLITUS PATIENT
  759. Enemy or ally? Fasting as an essential regulator of immune responses
  760. Nutritional needs in the older adult, guidelines and prevention strategies to optimize health and avoid chronic disease
  761. The Effects of Intermittent Fasting on Brain and Cognitive Function
  762. Parenteral nutrition in critical illness: total, supplemental or never?
  763. The ups and downs of caloric restriction and Fasting: from molecular effects to clinical application
  764. Benefits of Metformin Combined with Pemetrexed-Based Platinum Doublets as a First-Line Therapy for Advanced Lung Adenocarcinoma Patients with Diabetes
  765. The effect of Fasting and energy restricting Diets on markers of glucose and insulin controls: a systematic review and meta-analysis of randomized controlled trials
  766. Beyond calorie restriction: aging as a biological target for nutrient therapies
  767. Intermittent Fasting before Laparotomy: Effects on Glucose Control and Histopathologic Findings in Diabetic Rats
  768. Ganoderma lucidum stimulates autophagy-dependent longevity pathways in Caenorhabditis elegans and human cells
  769. Importance of circadian timing for aging and longevity
  770. Does daily Fasting shielding kidney on hyperglycemia-related inflammatory cytokine via TNF-α, NLRP3, TGF-β1 and VCAM-1 mRNA expression
  771. Dietary intervention as a therapeutic for cancer
  772. Atrial Fibrillation after Lung Cancer Surgery: Prediction, Prevention and Anticoagulation Management
  773. Interplay between the gut microbiome and metabolism in ulcerative colitis mice treated with the Dietary ingredient phloretin
  774. Prevalence of Germline Variants in a Large Cohort of Japanese Patients with Pheochromocytoma and/or Paraganglioma
  775. Latest Advances in the Effects of Caloric Restriction on Gut Microbiota in Healthy, Aged and Diseased Populations
  776. Intermittent Fasting: A User-Friendly Method for Type 2 Diabetes Mellitus
  777. Fed or fasted state for oral therapies in breast cancer treatment? A comprehensive review of clinical practice recommendations
  778. Sarcopenia: how to measure, when and why
  779. Combined intermittent Fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis
  780. Fasting and Exercise in Oncology: Potential Synergism of Combined Interventions
  781. Protective Features of Calorie Restriction on Cuprizone-induced Demyelination via Modulating Microglial Phenotype
  782. Nutritional interventions for spinal cord injury: preclinical efficacy and molecular mechanisms
  783. Tumor‐stroma ratio is associated with Miller‐Payne score and pathological response to neoadjuvant chemotherapy in HER2‐negative early breast cancer.
  784. The Intake of Extremely Low Minerals and Bacteria Consumable Saccharides Secured Safety and Persistent of 7-14 Days Prolonged Total Dietary Deprivation …
  785. Calorie Restriction as a New Treatment of Inflammatory Diseases
  786. Effects of caloric restriction on immunosurveillance, microbiota and cancer cell phenotype: possible implications for cancer treatment
  787. The Community of Practice Curriculum Development (CoP_CD) approach to develop self-efficacy and confidence in naturopathic medicine curriculum development.
  788. Pancreatic β cell regeneration induced by clinical and preclinical agents
  789. A comparative review of established Diets for prevention of cardiovascular disease and newer Dietary strategies
  790. A scoping review of intermittent Fasting, chronobiology, and metabolism
  791. Diversity of insulin and IGF signaling in breast cancer: Implications for therapy
  792. Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases
  793. Is Gut Dysbiosis an Epicenter of Parkinson’s Disease?
  794. A broader perspective of nutritional therapy for the critically ill
  795. Intermittent Fasting in paediatric critical illness: The properties and potential beneficial effects of an overnight fast in the PICU
  796. PTEN promoter methylation predicts 10-year prognosis in hormone receptor-positive early breast cancer patients who received adjuvant tamoxifen endocrine …
  797. Gut Microbiota-Derived Propionate Production May Explain Beneficial Effects of Intermittent Fasting in Experimental Colitis
  798. Designing Relevant Preclinical Rodent Models for Studying Links Between Nutrition, Obesity, Metabolism, and Cancer
  799. Intermittent protein restriction protects islet beta cells and improves glucose homeostasis in diabetic mice
  800. COVID-19 and obesity: Fighting two pandemics with intermittent Fasting
  801. Dysfunction of aged liver of male albino rats and the effect of intermitted Fasting; Biochemical, histological, and immunohistochemical study
  802. Impact of supervised beego, a traditional Chinese water-only Fasting, on thrombosis and haemostasis
  803. Advances in metformin‑based metabolic therapy for non‑small cell lung cancer
  804. Introduction to Dietary Research and Cancer
  805. PK Health and Performance Physical Activity Vs. Exercise
  806. Physiological responses to acute Fasting: implications for intermittent Fasting programs
  807. Role of Dietary modifications in the management of type 2 diabetic complications
  808. Time-Limited Eating and Continuous Glucose Monitoring in Adolescents with Obesity: A Pilot Study
  809. Plumbagin Elicits Cell-Specific Cytotoxic Effects and Metabolic Responses in Melanoma Cells
  810. Boosting NAD+ blunts toll-like receptor-4 induced type-I interferon in control and systemic lupus erythematosus monocytes
  811. A randomized controlled trial on the effects of the Chinese Medical Nutrition Therapy (CMNT) Diet on type 2 diabetes: study protocol
  812. The Anna Karenina model of β cell maturation in development and their dedifferentiation in type 1 and type 2 diabetes
  813. Time-restricted feeding improves blood glucose and insulin sensitivity in overweight patients with type 2 diabetes: a randomised controlled trial
  814. Safety, Feasibility, and Effects of Short-Term Calorie Reduction during Induction Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma: A Pilot Study
  815. Five‐day water‐only Fasting decreased metabolic‐syndrome risk factors and increased anti‐aging biomarkers without toxicity in a clinical trial of normal‐weight …
  816. A two-front nutritional environment fuels colorectal cancer: perspectives for Dietary intervention
  817. The Effects of Intermittent Fasting on Type 2 Diabetes
  818. Modulation of Intestinal Stem Cell Homeostasis by Nutrients: A Novel Therapeutic Option for Intestinal Diseases
  819. New promising developments for potential therapeutic applications of high-dose ascorbate as an anticancer drug
  820. Fecal Microbiota Transplantation: A Microbiome Modulation Technique for Alzheimer’s Disease
  821. Targeting Cardiovascular Risk Factors Through Dietary Adaptations and Caloric Restriction Mimetics
  822. Metabolic Reprogramming by Reduced Calorie Intake or Pharmacological Caloric Restriction Mimetics for Improved Cancer Immunotherapy
  823. Autophagic dysfunction of β cell dysfunction in type 2 diabetes, a double-edged sword
  824. MULTİPLE SKLEROZ BESLENME TEDAVİSİNDE GÜNCEL YAKLAŞIMLAR
  825. Repercussions of intermittent Fasting on the intestinal microbiota community and body composition: a systematic review
  826. Intermittent Fasting and Cognitive Performance–Targeting BDNF as Potential Strategy to Optimise Brain Health
  827. Association Between Depression and Breast Cancer: TNF/TNFRSF1β and LEP/LEPR Axis
  828. Gut microbiota—a positive contributor in the process of intermittent Fasting-mediated obesity control
  829. β-Hydroxybutyrate Attenuates Clinical Symptoms and Pain Behaviors in MOG-Induced Encephalomyelitis
  830. Effect of time restricted eating on body weight and Fasting glucose in participants with obesity: results of a randomized, controlled, virtual clinical trial
  831. Effect of Epidemic Intermittent Fasting on Metabolic Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials
  832. Short-term Ketogenic Diet Induces a Molecular Response that is Distinct from Dietary Protein Restriction
  833. Stem/progenitor cells in normal physiology and disease of the pancreas
  834. The effects of modified anti-inflammatory Diet on fatigue, quality of life, and inflammatory biomarkers in relapsing-remitting multiple sclerosis patients: a randomized …
  835. A multidisciplinary approach to optimizing care of patients treated with alpelisib
  836. Once-daily feeding is associated with better cognitive function and health in companion dogs: Results from the Dog Aging Project
  837. Exopolysaccharides from Lactobacillus plantarum NCU116 Facilitate Intestinal Homeostasis by Modulating Intestinal Epithelial Regeneration and Microbiota
  838. A Diet-microbial metabolism feedforward loop modulates intestinal stem cell renewal in the stressed gut
  839. Dietary nutrition for neurological disease therapy: Current status and future directions
  840. Anticancer innovative therapy congress: Highlights from the 10th anniversary edition
  841. Ketogenic Diet in cancer prevention and therapy: molecular targets and therapeutic opportunities
  842. Sleep and Biological Aging: A Short Review
  843. Evaluating the beneficial effects of Dietary restrictions: A framework for precision nutrigeroscience
  844. Impact of tight glucose control on circulating 3-hydroxybutyrate in critically ill patients
  845. Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment
  846. Strategies to prevent or remediate cancer and treatment-related aging
  847. Time Restricted Feeding Regulates Molecular Mechanisms with Involvement of Circadian Rhythm to Prevent Metabolic Diseases
  848. Avenues of research in Dietary interventions to target tumor metabolism in osteosarcoma
  849. Short term Fasting, IGF/insulin-axis and therapy outcome in patients with cancer
  850. Metabolic Strategies in Healthcare: A New Era
  851. Identification and Validation of Nutrient State-Dependent Serum Protein Mediators of Human CD4+ T Cell Responsiveness
  852. Effect of Dietary Methionine Deficiency Followed by a Re-Feeding Phase on the Hepatic Antioxidant Activities of Lambs
  853. Asprosin Role for Obese Male Patients with Diabetic Mellitus Type II
  854. Integrative Geriatric Nutrition
  855. Effects of common weight loss plans on diabetes mellitus and cardiovascular risk factors
  856. LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress–Based Treatments
  857. Time restricted feeding and mental health: A review of possible mechanisms on affective and cognitive disorders
  858. Multiomic Predictors of Short‐Term Weight Loss and Clinical Outcomes During a Behavioral‐Based Weight Loss Intervention
  859. Evidence gaps and potential roles of intermittent Fasting in the prevention of chronic diseases
  860. The effect of caloric restriction and Fasting on cancer
  861. Nutritional interventions targeting gut microbiota during cancer therapies
  862. The Influence of Fasting and Energy Restricting Diets on Blood Pressure in Humans: A Systematic Review and Meta‑Analysis
  863. Glucose Limitation Sensitizes Cancer Cells to Selenite-Induced Cytotoxic Effect via SLC7A11-Mediated Redox Collapse
  864. Fasting increases microbiome-based colonization resistance and reduces host inflammatory responses during an enteric bacterial infection
  865. Metabolic Regulation of Stem Cells in Aging
  866. Association between time restricted feeding and cognitive status in older Italian adults
  867. Mental and Behavioural Responses to Bahá’í Fasting: Looking Behind the Scenes of a Religiously Motivated Intermittent Dry Fast Using a Mixed Methods Approach
  868. Metabolic and Signaling Roles of Ketone Bodies in Health and Disease
  869. Calorie Restriction for Cancer Prevention and Therapy: Mechanisms, Expectations, and Efficacy
  870. Blood pressure, body mass index lowering and ketogenesis in Qigong Bigu
  871. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes
  872. Impact of different durations of Fasting on intestinal autophagy and serum metabolome in broiler chicken
  873. Role of Gut Microbiota in Autoimmune Diseases: A Review
  874. Fasting impairs type 2 helper T cell infiltration in the lung of an eosinophilic asthma mouse model
  875. Mining the Gut Microbiota for Microbial-Based Therapeutic Strategies in Cancer Immunotherapy
  876. PathoBiochemistry-directed Guidelines for COVID-19
  877. Aging and Cancer: The Waning of Community Bonds
  878. Approach to Obesity in the Elderly
  879. Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor–Positive Advanced Breast Cancer (EVERMET …
  880. Altered Gut Microbiota in a Fragile X Syndrome Mouse Model
  881. Metabolic regulation of T cells in the tumor microenvironment by nutrient availability and Diet
  882. Impact of Body Mass Index on the Age of Relapsing-Remitting Multiple Sclerosis Onset: A Retrospective Study
  883. Fasting before living-kidney donation: effect on donor well-being and postoperative recovery: study protocol of a multicenter randomized controlled trial
  884. Glucose Limitation Sensitizes Cancer Cells to Selenite-Induced Cytotoxicity via SLC7A11-Mediated Redox Collapse
  885. Short-Term Calorie Restriction Maintains Plasma Insulin Concentrations along with a Reduction in Hepatic Insulin-Degrading Enzyme Levels in db/db Mice
  886. Cytoplasmic DNA sensing by KU complex in aged CD4+ T cell potentiates T cell activation and aging-related autoimmune inflammation
  887. Fasting reverses drug-resistance in hepatocellular carcinoma through p53-dependent metabolic synergism
  888. Internal connections between Dietary intake and gut microbiota homeostasis in disease progression of ulcerative colitis: a review
  889. The functional medicine approach to atrial fibrillation: can a cure for atrial fibrillation be found in the gut?
  890. Beta-hydroxybutyrate, friend or foe for stressed hearts
  891. Is Non-Alcoholic Fatty Pancreatic Disease a Mechanism of Beta‐cells Dedifferentiation to Trigger Type 2 Diabetes Mellitus?
  892. Application of Metabolomics in the Study of Starvation-Induced Autophagy in Saccharomyces cerevisiae: A Scoping Review
  893. Efficacy of Dietary and supplementation interventions for individuals with type 2 diabetes
  894. Early-stage Hyperglycemia-induced Gut Microbial Changes Are Partially Associated with Mechanical Allodynia in db/db Mice
  895. The effects of Ramadan intermittent Fasting on liver function in healthy adults: A systematic review, meta-analysis, and meta-regression
  896. Calorie restriction or Dietary restriction: how far they can protect the brain against neurodegenerative diseases?
  897. Effect of early time-restricted feeding on the metabolic profile of adults with excess weight: A systematic review with meta-analysis
  898. A companion guide for health care professionals
  899. Optically activatable photosynthetic bacteria-based highly tumor specific immunotheranostics
  900. Effects of anti-aging interventions on intestinal microbiota
  901. High Levels of Prebiotic Resistant Starch in Diet Modulate a Specific Pattern of miRNAs Expression Profile Associated to a Better Overall Survival in Pancreatic …
  902. Preoperative Fasting confers protection against intestinal ischaemia/reperfusion injury by modulating gut microbiota and their metabolites in a mouse model
  903. Effects of Dietary restriction on neuroinflammation in neurodegenerative diseases
  904. Hyperleptinemia in obese state renders luminal breast cancers refractory to tamoxifen by coordinating a crosstalk between Med1, miR205 and ErbB
  905. Dietary protein and amino acid restriction: Roles in metabolic health and aging-related diseases
  906. Calorie intake rather than food quantity consumed is the key factor for the anti-aging effect of calorie restriction
  907. Metabolically Supported Chemotherapy for Managing End-Stage Breast Cancer: A Complete and Durable Response
  908. Additive Antiproliferative and Antiangiogenic Effects of Metformin and Pemetrexed in a Non-Small-Cell Lung Cancer Xenograft Model
  909. Dietary Research and Cancer
  910. Does intermittent Fasting associated with aerobic training influence parameters related to the gut-brain axis of Wistar rats?
  911. Autophagy in the cancer-immunity dialogue
  912. Glucose starvation suppresses gastric cancer through targeting miR-216a-5p/Farnesyl-Diphosphate Farnesyltransferase 1 axis
  913. Myelodysplastic Syndromes and Metabolism
  914. IF1 inactivation attenuates experimental colitis through downregulation of neutrophil infiltration in colon mucosa
  915. Growth Hormone/Insulin Growth Factor Axis in Sex Steroid Associated Disorders and Related Cancers
  916. High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer
  917. METABOLIC SYNDROME AND INFLAMMATORY CYTOKINES IN PSORIASIS
  918. Dietary intervention impacts immune cell functions and dynamics by inducing metabolic rewiring
  919. Acetone Ingestion Mimics a Fasting State to Improve Glucose Tolerance in a Mouse Model of Gestational Hyperglycemia
  920. Hotspots and trends in liver kinase B1 research: A bibliometric analysis
  921. Intermittent Energy Restriction, Weight Loss and Cardiometabolic Risk: A Critical Appraisal of Evidence in Humans
  922. Using dynamic cell communication improves treatment strategies of breast cancer
  923. Dietary factors in experimental autoimmune encephalomyelitis and multiple sclerosis: A comprehensive review
  924. Contribution of the tumor and obese microenvironment to triple negative breast cancer
  925. Illness perceptions and health-related quality of life in individuals with overweight and obesity
  926. Evaluation of the Effect of Erynjium Alcoholic Extract on Increasing Insulin Sensitivity: By Evaluating Hyperglycemia and Dyslipidemia in an Animal Model of …
  927. Protective effects of prucalopride in MPTP-induced Parkinson’s disease mice: Neurochemistry, motor function and gut barrier
  928. Diet as a risk factor and intervention for lower urinary tract symptoms secondary to benign prostatic hyperplasia
  929. Applicability of time-restricted eating for the prevention of lifestyle-dependent diseases in a working population: results of a pilot study in a pre-post design
  930. A Mediterranean-type Diet improved systemic inflammation in multiple sclerosis patients, as compared to the traditional Iranian Diet: A single-center randomized …
  931. Ketogenic Diet protects myelin and axons in diffuse axonal injury
  932. Effects of daytime dry Fasting on hydration, glucose metabolism and circadian phase: a prospective exploratory cohort study in Bahá’í volunteers
  933. The effect of menthol supplement Diet on colitis-induced colon tumorigenesis and intestinal microbiota
  934. Beneficial Effects on Brain Micro-Environment by Caloric Restriction in Alleviating Neurodegenerative Diseases and Brain Aging
  935. Effect of epidemic intermittent Fasting on cardiometabolic risk factors: A systematic review and meta-analysis of randomized controlled trials
  936. Advances in Postprandial Hypotension and the Impact of Diabetes Mellitus on Its Pathogenesis and Treatment
  937. Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients
  938. Nutritional Preconditioning in Cancer Treatment in Relation to DNA Damage and Aging
  939. The Fact and Fiction of Nutritional Claims About Health and Longevity
  940. Determination of ketone bodies in biological samples via rapid UPLC-MS/MS
  941. The Diverse Roles of Heme Oxygenase-1 in Tumor Progression
  942. Transgenerational fitness effects of lifespan extension by Dietary restriction in Caenorhabditis elegans
  943. Therapeutic effect of baicalin on inflammatory bowel disease: A review
  944. Higher ambient temperature is associated with worsening of HbA1c levels in a Saudi population
  945. Insulin resistance per se drives early and reversible dysbiosis-mediated gut barrier impairment and bactericidal dysfunction
  946. Live Longer, but How? Nutrition and Aging
  947. The Effect of Dietary Products with Estrogenic Properties on Breast Cancer in Women Over 50
  948. Targeting senescent cells for vascular aging and related diseases
  949. The impact of healthy lifestyles on academic achievement among Italian adolescents
  950. GRB10 regulates β cell mass by inhibiting β cell proliferation and stimulating β cell dedifferentiation
  951. PEA/Polydatin: Anti-Inflammatory and Antioxidant Approach to Counteract DNBS-Induced Colitis
  952. Caloric and nutrient restriction to augment chemotherapy efficacy for acute lymphoblastic leukemia: the IDEAL trial
  953. Tuning up an aged clock: Circadian clock regulation in metabolism and aging
  954. The Influence of Diet and Probiotics on the Response of Solid Tumours to Immunotherapy: Present and Future Perspectives
  955. Polysaccharides from Sargassum fusiforme after UV/H 2 O 2 degradation effectively ameliorate dextran sulfate sodium-induced colitis
  956. Drug Repurposing: An Avenue Toward Stress Medicine in Cancer Therapy
  957. Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic KRAS mutant colon cancer
  958. Visceral Adiposity and Cancer: Role in Pathogenesis and Prognosis
  959. The role of gut dysbiosis in Parkinson’s disease: mechanistic insights andtherapeutic options
  960. Efficacy of a functional therapy program for depression and C-reactive protein: A pilot study
  961. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression …
  962. Pegylated arginine deiminase drives arginine turnover and systemic autophagy to dictate energy metabolism
  963. Shining a light on metabolic vulnerabilities in non-small cell lung cancer
  964. Cancer metabolism and Dietary interventions
  965. Pleiotropic Effects of Glucocorticoids on the Immune System in Circadian Rhythm and Stress
  966. 16 Nutrition and Chemotherapy
  967. Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation
  968. Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction
  969. Immunosenescence in multiple sclerosis: the identification of new therapeutic targets
  970. Ascorbate kills breast cancer cells by rewiring metabolism via redox imbalance and energy crisis
  971. Myelin Repair: From Animal Models to Humans
  972. Obesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectives
  973. Colonic Dopaminergic Neurons Changed Reversely With Those in the Midbrain via Gut Microbiota-Mediated Autophagy in a Chronic Parkinson’s Disease …
  974. Caloric restriction mimetics for the treatment of cardiovascular diseases
  975. Prevalence and demographic, substance use, and mental health correlates of Fasting among US college students
  976. Reversion of early-and late-stage β-cell dedifferentiation by human umbilical cord-derived mesenchymal stem cells in type 2 diabetic mice
  977. CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes Mellitus
  978. Reversal of the renal hyperglycemic memory by targeting sustained tubular p21 expression
  979. NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases
  980. Rodent Diet aids and the fallacy of caloric restriction
  981. Systematic Review The effects of Ramadan intermittent Fasting on liver function in healthy adults: A systematic review, meta-analysis, and meta-regression
  982. Metformin inhibits human non-small cell lung cancer by regulating AMPK–CEBPB–PDL1 signaling pathway
  983. A plant-based Diet and healthy lifestyle lower C-reactive protein levels
  984. Psychological and Sleep
  985. Dysbiosis, malnutrition and enhanced gut-lung axis contribute to age-related respiratory diseases
  986. Stage-specific transcriptomic changes in pancreatic α-cells after massive β-cell loss
  987. Fasting Induces a Highly Resilient Deep Quiescent State in Muscle Stem Cells via Ketone Body Signaling
  988. Exercise and Nutritional Strategies to Promote Weight Loss: A Narrative Review1
  989. Guidelines for reporting on animal fecal transplantation (GRAFT) studies: recommendations from a systematic review of murine transplantation protocols
  990. Debates in Pancreatic Beta Cell Biology: Proliferation Versus Progenitor Differentiation and Transdifferentiation in Restoring β Cell Mass
  991. Ten things to know about ten cardiovascular disease risk factors
  992. Injury and regeneration in renal aging
  993. Exercise and Nutritional Strategies to Promote Weight Loss: A Narrative
  994. NAD modulates DNA methylation and cell differentiation
  995. The Effects of Two Different Dietary Regimens During Exercise On Outcome of Experimental Acute Kidney Injury
  996. New Pandemic: Obesity and Associated Nephropathy
  997. DSS-induced colitis is associated with adipose tissue dysfunction and disrupted hepatic lipid metabolism leading to hepatosteatosis and dyslipidemia in mice
  998. The effects of plant-based Diets on pancreatic beta-cell function: A systematic review
  999. The Diverse Roles of Heme Oxygenase-1 in Tumor Progression.
  1000. Deciphering the nonsense-mediated mRNA decay pathway to identify cancer cell vulnerabilities for effective cancer therapy
  1001. Hippo Signaling Pathway in Pancreas Development
  1002. Ascorbate is a multifunctional micronutrient whose synthesis is lacking in primates
  1003. SETD4-expressing cells contribute to pancreatic development and response to cerulein induced pancreatitis injury
  1004. Oxidative Stress and the Intersection of Oncogenic Signaling and Metabolism in Squamous Cell Carcinomas
  1005. The Comparison of the Effects between Continuous and Intermittent Energy Restriction in Short-Term Bodyweight Loss for Sedentary Population: A Randomized …
  1006. High-dose vitamin C: preclinical evidence for tailoring treatment in cancer patients
  1007. Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade
  1008. Natural antioxidants in new age-related diseases
  1009. LncRNA Malat1 regulates iPSC-derived β-cell differentiation by targeting the miR-15b-5p/Ihh axis
  1010. Directing T-cell immune responses for cancer vaccination and immunotherapy. Vaccines 2021, 9, x
  1011. Urinary metabolomic changes and microbiotic alterations in presenilin1/2 conditional double knockout mice
  1012. Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease
  1013. RNA m6A Modification: The Mediator Between Cellular Stresses and Biological Effects
  1014. Sodium butyrate attenuates rotenone-induced toxicity by activation of autophagy through epigenetically regulating PGC-1α expression in PC12 cells
  1015. Nutrition and Immune Function
  1016. Phenotypic and functional heterogeneity of monocyte subsets in chronic heart failure patients
  1017. Reinforcing one-carbon metabolism via folic acid/Folr1 promotes β-cell differentiation
  1018. Physiological activation of the nephron central command drives endogenous kidney tissue regeneration
  1019. Immunometabolism in the Tumor Microenvironment
  1020. Say No To Arthritis: The proven drug-free guide to preventing and relieving arthritis
  1021. Therapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy?
  1022. The Panda-Derived Lactobacillus plantarum G201683 Alleviates the Inflammatory Response in DSS-Induced Panda Microbiota-Associated Mice
  1023. Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer
  1024. The Association of Altered Gut Microbiota and Intestinal Mucosal Barrier Integrity in Mice With Heroin Dependence
  1025. Unravelling the role of gut microbiota in Parkinson’s disease progression: Pathogenic and therapeutic implications
  1026. Chicoric acid prevents neurodegeneration via microbiota-gut-brain axis in a mouse Parkinson’s disease model
  1027. INCREASING SOCIAL SUPPORT
  1028. Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
  1029. Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy
  1030. Vitamin C (ascorbate) and redox topics in cancer
  1031. The Plant Power Doctor: A simple prescription for a healthier you (Includes delicious recipes to transform your health)
  1032. INTESTINAL MICROBIOTA IS A MAJOR DETERMINANT IN THE RESPONSE TO ONCOLYTIC VACCINE IN A MOUSE MODEL OF MELANOMA
  1033. Finding and Visualizing Network-Based Multi-Omic Predictive Models
  1034. The Last Adam and Slowing Aging
  1035. Inflammation-Induced Tumorigenesis and Metastasis
  1036. Phenotypic landscape of intestinal organoid development
  1037. A fishing expedition for antidiabetic drugs: identifying new avenues to stimulate beta-cell regeneration
  1038. Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers
  1039. The Pain-Free Mindset: 7 Steps to Taking Control and Overcoming Chronic Pain

 

Related Posts

Shopping Cart
Scroll to Top